Acceder Registro /

Bárbara Bonacasa

Buscador

Marín F, Bonacasa B, Valdés M. Glycoprotein inhibitors in patients on chronic anticoagulation: safe enough or too much risk? Thromb Haemost. 2010 Jan;103(1):11-2. doi: 10.1160/TH09-10-0694. Epub 2009 Dec 1. PubMed PMID: 20062940.
AÑO: 2010; IF: 6.681
Cambronero F, Vilchez JA, García-Honrubia A, Ruiz-Espejo F, Moreno V, Hernández-Romero D, Bonacasa B, González-Conejero R, de la Morena G, Martínez P, Climent V, Valdés M, Marín F. Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathy. Thromb Res. 2010 Jul;126(1):e46-50. doi: 10.1016/j.thromres.2010.01.010. Epub 2010 Feb 13. PubMed PMID: 20156645.
AÑO: 2010; IF: 10.407
Mann GE, Bonacasa B, Ishii T, Siow RC. Targeting the redox sensitive Nrf2-Keap1 defense pathway in cardiovascular disease: protection afforded by dietary isoflavones. Curr Opin Pharmacol. 2009 Apr;9(2):139-45. doi: 10.1016/j.coph.2008.12.012. Epub 2009 Jan 20. Review. PubMed PMID: 19157984.
AÑO: 2009; IF: 4.768
Bonacasa B, Sanchez ML, Rodriguez F, Lopez B, Quesada T, Fenoy FJ, Hernández I. 2-Methoxyestradiol attenuates hypertension and coronary vascular remodeling in spontaneously hypertensive rats. Maturitas. 2008 Dec 20;61(4):310-6. doi: 10.1016/j.maturitas.2008.09.028. Epub 2008 Nov 17. PubMed PMID: 19010616.
AÑO: 2008; IF: 5.11
Giménez J, Garcia PM, Bonacasa B, Carbonell LF, Quesada T, Hernández I. Effects of oestrogen treatment and angiotensin-converting enzyme inhibition on the microvasculature of ovariectomized spontaneously hypertensive rats. Exp Physiol. 2006 Jan;91(1):261-8. Epub 2005 Nov 10. PubMed PMID: 16282368.
AÑO: 2006; IF: 2.858

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R